APO RESEARCH · REPORT
Medical Grade Chitosan
Chitosan (CS) is a linear polysaccharide which is achieved by deacetylation of chitin, which is the second most plentiful compound in nature, after cellulose. Chitosan was applied in pharmaceutics/drug/gene delivery and cell encapsulation. Chitosan was applied in binding to protein drugs, contact lenses and implants. GMP grade chitosan covers chitosan for a variety of medical applications.
Product & engineering
Understand the product.
Chitosan (CS) is a linear polysaccharide which is achieved by deacetylation of chitin, which is the second most plentiful compound in nature, after cellulose. Chitosan was applied in pharmaceutics/drug/gene delivery and cell encapsulation. Chitosan was applied in binding to protein drugs, contact lenses and implants. GMP grade chitosan covers chitosan for a variety of medical applications.
Selected research
Market Structure
Global Medical Grade Chitosan Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Chitosan (CS) is a linear polysaccharide which is achieved by deacetylation of chitin, which is the second most plentiful compound in nature, after cellulose. Chitosan was applied in pharmaceutics/drug/gene delivery and cell encapsulation. Chitosan was applied in binding to protein drugs, contact lenses and implants. GMP grade chitosan covers chitosan for a variety of medical applications.
The industry's leading producers are Primex, KitoZyme and BIO21, with a combined revenue share of 29.72% in 2019.
This report provides an overview of the global Medical Grade Chitosan market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Medical Grade Chitosan and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical Grade Chitosan sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Grade Chitosan market size, projected growth trends, production technologies, key applications, and end-use industries.
Medical Grade Chitosan Segment by Company
Primex
KitoZyme
BIO21
YSK
Vietnam Food
NovaMatrix
KIMICA
Ningbo Zhenhai Haixin Biological
Golden-Shell Pharmaceutical
Zhejiang Fengrun Biotech
Jiangsu Shuanglin
Jiangsu Aoxin Biotechnology
Qingdao Yunzhou Biochemistry
Medical Grade Chitosan Segment by Type
Animal Origin Chitosan
Plant Based Chitosan
Medical Grade Chitosan Segment by Application
Wound Care
Healthcare Products
Antibacterial Products
Others
Medical Grade Chitosan Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Grade Chitosan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Grade Chitosan and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Grade Chitosan.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Medical Grade Chitosan market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medical Grade Chitosan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medical Grade Chitosan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Medical Grade Chitosan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Animal Origin Chitosan
- Plant Based Chitosan
Applications
- Wound Care
- Healthcare Products
- Antibacterial Products
- Others
Companies covered
- Primex
- KitoZyme
- BIO21
- YSK
- Vietnam Food
- NovaMatrix
- KIMICA
- Ningbo Zhenhai Haixin Biological
- Golden-Shell Pharmaceutical
- Zhejiang Fengrun Biotech
- Jiangsu Shuanglin
- Jiangsu Aoxin Biotechnology
- Qingdao Yunzhou Biochemistry
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Medical Grade Chitosan Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Medical Grade Chitosan Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Medical Grade Chitosan Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Medical Grade Chitosan Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Medical Grade Chitosan Market Dynamics
- 2.1 Medical Grade Chitosan Industry Trends
- 2.2 Medical Grade Chitosan Industry Drivers
- 2.3 Medical Grade Chitosan Industry Opportunities and Challenges
- 2.4 Medical Grade Chitosan Industry Restraints
3 Medical Grade Chitosan Market by Manufacturers
- 3.1 Global Medical Grade Chitosan Revenue by Manufacturers (2021-2026)
- 3.2 Global Medical Grade Chitosan Sales by Manufacturers (2021-2026)
- 3.3 Global Medical Grade Chitosan Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Medical Grade Chitosan Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Medical Grade Chitosan Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Medical Grade Chitosan Manufacturers, Product Type & Application
- 3.7 Global Medical Grade Chitosan Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Medical Grade Chitosan Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Medical Grade Chitosan Players Market Share by Revenue in 2025
- 3.8.3 2025 Medical Grade Chitosan Tier 1, Tier 2, and Tier 3
4 Medical Grade Chitosan Market by Type
- 4.1 Medical Grade Chitosan Type Introduction
- 4.1.1 Animal Origin Chitosan
- 4.1.2 Plant Based Chitosan
- 4.2 Global Medical Grade Chitosan Sales by Type
- 4.2.1 Global Medical Grade Chitosan Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Medical Grade Chitosan Sales by Type (2021-2032)
- 4.2.3 Global Medical Grade Chitosan Sales Market Share by Type (2021-2032)
- 4.3 Global Medical Grade Chitosan Revenue by Type
- 4.3.1 Global Medical Grade Chitosan Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Medical Grade Chitosan Revenue by Type (2021-2032)
- 4.3.3 Global Medical Grade Chitosan Revenue Market Share by Type (2021-2032)
5 Medical Grade Chitosan Market by Application
- 5.1 Medical Grade Chitosan Application Introduction
- 5.1.1 Wound Care
- 5.1.2 Healthcare Products
- 5.1.3 Antibacterial Products
- 5.1.4 Others
- 5.2 Global Medical Grade Chitosan Sales by Application
- 5.2.1 Global Medical Grade Chitosan Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Medical Grade Chitosan Sales by Application (2021-2032)
- 5.2.3 Global Medical Grade Chitosan Sales Market Share by Application (2021-2032)
- 5.3 Global Medical Grade Chitosan Revenue by Application
- 5.3.1 Global Medical Grade Chitosan Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Medical Grade Chitosan Revenue by Application (2021-2032)
- 5.3.3 Global Medical Grade Chitosan Revenue Market Share by Application (2021-2032)
6 Global Medical Grade Chitosan Sales by Region
- 6.1 Global Medical Grade Chitosan Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Medical Grade Chitosan Sales by Region (2021-2032)
- 6.2.1 Global Medical Grade Chitosan Sales by Region (2021-2026)
- 6.2.2 Global Medical Grade Chitosan Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Medical Grade Chitosan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Medical Grade Chitosan Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Medical Grade Chitosan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Medical Grade Chitosan Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Medical Grade Chitosan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Medical Grade Chitosan Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Medical Grade Chitosan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Medical Grade Chitosan Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Medical Grade Chitosan Revenue by Region
- 7.1 Global Medical Grade Chitosan Revenue by Region
- 7.1.1 Global Medical Grade Chitosan Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Medical Grade Chitosan Revenue by Region (2021-2026)
- 7.1.3 Global Medical Grade Chitosan Revenue by Region (2027-2032)
- 7.1.4 Global Medical Grade Chitosan Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Medical Grade Chitosan Revenue (2021-2032)
- 7.2.2 North America Medical Grade Chitosan Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Medical Grade Chitosan Revenue (2021-2032)
- 7.3.2 Europe Medical Grade Chitosan Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Medical Grade Chitosan Revenue (2021-2032)
- 7.4.2 Asia-Pacific Medical Grade Chitosan Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Medical Grade Chitosan Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Medical Grade Chitosan Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Primex
- 8.1.1 Primex Company Information
- 8.1.2 Primex Business Overview
- 8.1.3 Primex Medical Grade Chitosan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Primex Medical Grade Chitosan Product Portfolio
- 8.1.5 Primex Recent Developments
- 8.2 KitoZyme
- 8.2.1 KitoZyme Company Information
- 8.2.2 KitoZyme Business Overview
- 8.2.3 KitoZyme Medical Grade Chitosan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 KitoZyme Medical Grade Chitosan Product Portfolio
- 8.2.5 KitoZyme Recent Developments
- 8.3 BIO21
- 8.3.1 BIO21 Company Information
- 8.3.2 BIO21 Business Overview
- 8.3.3 BIO21 Medical Grade Chitosan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 BIO21 Medical Grade Chitosan Product Portfolio
- 8.3.5 BIO21 Recent Developments
- 8.4 YSK
- 8.4.1 YSK Company Information
- 8.4.2 YSK Business Overview
- 8.4.3 YSK Medical Grade Chitosan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 YSK Medical Grade Chitosan Product Portfolio
- 8.4.5 YSK Recent Developments
- 8.5 Vietnam Food
- 8.5.1 Vietnam Food Company Information
- 8.5.2 Vietnam Food Business Overview
- 8.5.3 Vietnam Food Medical Grade Chitosan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Vietnam Food Medical Grade Chitosan Product Portfolio
- 8.5.5 Vietnam Food Recent Developments
- 8.6 NovaMatrix
- 8.6.1 NovaMatrix Company Information
- 8.6.2 NovaMatrix Business Overview
- 8.6.3 NovaMatrix Medical Grade Chitosan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 NovaMatrix Medical Grade Chitosan Product Portfolio
- 8.6.5 NovaMatrix Recent Developments
- 8.7 KIMICA
- 8.7.1 KIMICA Company Information
- 8.7.2 KIMICA Business Overview
- 8.7.3 KIMICA Medical Grade Chitosan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 KIMICA Medical Grade Chitosan Product Portfolio
- 8.7.5 KIMICA Recent Developments
- 8.8 Ningbo Zhenhai Haixin Biological
- 8.8.1 Ningbo Zhenhai Haixin Biological Company Information
- 8.8.2 Ningbo Zhenhai Haixin Biological Business Overview
- 8.8.3 Ningbo Zhenhai Haixin Biological Medical Grade Chitosan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Ningbo Zhenhai Haixin Biological Medical Grade Chitosan Product Portfolio
- 8.8.5 Ningbo Zhenhai Haixin Biological Recent Developments
- 8.9 Golden-Shell Pharmaceutical
- 8.9.1 Golden-Shell Pharmaceutical Company Information
- 8.9.2 Golden-Shell Pharmaceutical Business Overview
- 8.9.3 Golden-Shell Pharmaceutical Medical Grade Chitosan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Golden-Shell Pharmaceutical Medical Grade Chitosan Product Portfolio
- 8.9.5 Golden-Shell Pharmaceutical Recent Developments
- 8.10 Zhejiang Fengrun Biotech
- 8.10.1 Zhejiang Fengrun Biotech Company Information
- 8.10.2 Zhejiang Fengrun Biotech Business Overview
- 8.10.3 Zhejiang Fengrun Biotech Medical Grade Chitosan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Zhejiang Fengrun Biotech Medical Grade Chitosan Product Portfolio
- 8.10.5 Zhejiang Fengrun Biotech Recent Developments
- 8.11 Jiangsu Shuanglin
- 8.11.1 Jiangsu Shuanglin Company Information
- 8.11.2 Jiangsu Shuanglin Business Overview
- 8.11.3 Jiangsu Shuanglin Medical Grade Chitosan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Jiangsu Shuanglin Medical Grade Chitosan Product Portfolio
- 8.11.5 Jiangsu Shuanglin Recent Developments
- 8.12 Jiangsu Aoxin Biotechnology
- 8.12.1 Jiangsu Aoxin Biotechnology Company Information
- 8.12.2 Jiangsu Aoxin Biotechnology Business Overview
- 8.12.3 Jiangsu Aoxin Biotechnology Medical Grade Chitosan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Jiangsu Aoxin Biotechnology Medical Grade Chitosan Product Portfolio
- 8.12.5 Jiangsu Aoxin Biotechnology Recent Developments
- 8.13 Qingdao Yunzhou Biochemistry
- 8.13.1 Qingdao Yunzhou Biochemistry Company Information
- 8.13.2 Qingdao Yunzhou Biochemistry Business Overview
- 8.13.3 Qingdao Yunzhou Biochemistry Medical Grade Chitosan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Qingdao Yunzhou Biochemistry Medical Grade Chitosan Product Portfolio
- 8.13.5 Qingdao Yunzhou Biochemistry Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Medical Grade Chitosan Value Chain Analysis
- 9.1.1 Medical Grade Chitosan Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Medical Grade Chitosan Production Mode & Process
- 9.2 Medical Grade Chitosan Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Medical Grade Chitosan Distributors
- 9.2.3 Medical Grade Chitosan Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst